Anti-Tuberculosis Compounds
- Summary
- Novel Mycobacterium tuberculosis thioredoxin reductase inhibitors with antimycobacterial activity in infected macrophages that overcomes problems of current anti-tuberculotics.
![](/Content/images/common/Partners/125.png)
For more information, please click Here